Acuta Capital Partners, LLC Argenx Se Transaction History

Acuta Capital Partners, LLC

  • $53.1 Million
  • Q3 2025

A detailed history of Acuta Capital Partners, LLC transactions in Argenx Se stock. As of the latest transaction made, Acuta Capital Partners, LLC holds 6,379 shares of ARGX stock, worth $5.79 Million. This represents 8.86% of its overall portfolio holdings.

Number of Shares
6,379
Previous 6,702 4.82%
Holding current value
$5.79 Million
Previous $3.69 Million 27.34%
% of portfolio
8.86%
Previous 9.18%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025
SELL
$538.64 - $768.0 $173,980 - $248,064
-323 Reduced 4.82%
6,379 $4.7 Million
Q2 2025

Aug 14, 2025
SELL
$532.27 - $656.65 $170,858 - $210,784
-321 Reduced 4.57%
6,702 $3.69 Million
Q1 2025

May 15, 2025
BUY
$571.0 - $671.75 $64,523 - $75,907
113 Added 1.64%
7,023 $4.16 Million
Q4 2024

Feb 14, 2025
BUY
$520.52 - $638.33 $525,725 - $644,713
1,010 Added 17.12%
6,910 $4.25 Million
Q3 2024

Nov 14, 2024
BUY
$434.22 - $551.9 $825,018 - $1.05 Million
1,900 Added 47.5%
5,900 $3.2 Million
Q2 2024

Aug 14, 2024
BUY
$356.01 - $451.55 $1.42 Million - $1.81 Million
4,000 New
4,000 $1.72 Million
Q4 2023

Feb 14, 2024
BUY
$338.91 - $506.01 $813,384 - $1.21 Million
2,400 New
2,400 $913,000
Q2 2023

Aug 14, 2023
BUY
$360.14 - $422.58 $1.07 Million - $1.26 Million
2,974 Added 31.0%
12,568 $4.9 Million
Q1 2023

May 15, 2023
BUY
$334.23 - $403.65 $1.5 Million - $1.81 Million
4,494 Added 88.12%
9,594 $3.57 Million
Q4 2022

Feb 14, 2023
BUY
$342.17 - $402.31 $1.75 Million - $2.05 Million
5,100 New
5,100 $1.93 Million
Q4 2019

Feb 14, 2020
SELL
$106.59 - $164.21 $2.4 Million - $3.69 Million
-22,500 Closed
0 $0
Q3 2019

Nov 14, 2019
SELL
$113.31 - $150.51 $6.63 Million - $8.8 Million
-58,500 Reduced 72.22%
22,500 $2.56 Million
Q2 2019

Aug 14, 2019
BUY
$115.0 - $141.58 $2.01 Million - $2.48 Million
17,500 Added 27.56%
81,000 $11.5 Million
Q1 2019

May 14, 2019
BUY
$98.85 - $134.59 $1.04 Million - $1.41 Million
10,500 Added 19.81%
63,500 $7.93 Million
Q4 2018

Feb 14, 2019
SELL
$63.81 - $109.82 $3.32 Million - $5.71 Million
-52,000 Reduced 49.52%
53,000 $5.09 Million
Q3 2018

Nov 07, 2018
SELL
$75.5 - $96.63 $26.3 Million - $33.6 Million
-348,233 Reduced 76.83%
105,000 $7.96 Million
Q2 2018

Aug 15, 2018
BUY
$74.84 - $100.16 $3.7 Million - $4.95 Million
49,412 Added 12.24%
453,233 $37.6 Million
Q1 2018

May 15, 2018
BUY
$56.95 - $85.19 $4.6 Million - $6.89 Million
80,821 Added 25.02%
403,821 $32.5 Million
Q4 2017

Feb 14, 2018
BUY
$22.57 - $63.56 $2.41 Million - $6.78 Million
106,745 Added 49.36%
323,000 $20.4 Million
Q3 2017

Nov 14, 2017
BUY
$19.81 - $22.61 $4.28 Million - $4.89 Million
216,255
216,255 $4.89 Million

Others Institutions Holding ARGX

# of Institutions
526
Shares Held
26M
Call Options Held
589K
Put Options Held
320K
View Full List

About ARGENX SE

ARGX Quotes by TradingView
  • Ticker ARGX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,323,800
  • Market Cap $50.2B
  • Description
  • argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...
More about ARGX
Track This Portfolio

Track Acuta Capital Partners, LLC Portfolio

Follow Acuta Capital Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Acuta Capital Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Acuta Capital Partners, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email